ID30484A - Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin - Google Patents

Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin

Info

Publication number
ID30484A
ID30484A IDW00200101897A ID20011897A ID30484A ID 30484 A ID30484 A ID 30484A ID W00200101897 A IDW00200101897 A ID W00200101897A ID 20011897 A ID20011897 A ID 20011897A ID 30484 A ID30484 A ID 30484A
Authority
ID
Indonesia
Prior art keywords
methods
phenoxic
heterosiclicsulfonamidyl
endoteline
derunan
Prior art date
Application number
IDW00200101897A
Other languages
English (en)
Indonesian (id)
Inventor
Volker Breu
Phillippe Coassolo
Werner Neidhart
Sebastien Roux
Peter Weiss
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ID30484A publication Critical patent/ID30484A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IDW00200101897A 1999-03-03 2000-02-28 Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin ID30484A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99104306 1999-03-03

Publications (1)

Publication Number Publication Date
ID30484A true ID30484A (id) 2001-12-13

Family

ID=8237697

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101897A ID30484A (id) 1999-03-03 2000-02-28 Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin

Country Status (30)

Country Link
US (2) US6417360B1 (fr)
EP (1) EP1185525B1 (fr)
JP (1) JP3488203B2 (fr)
KR (1) KR100478798B1 (fr)
CN (1) CN1342158B (fr)
AR (1) AR044720A1 (fr)
AT (1) ATE353325T1 (fr)
AU (1) AU756738B2 (fr)
BR (1) BR0008717A (fr)
CA (1) CA2364906C (fr)
CY (1) CY1108002T1 (fr)
CZ (1) CZ300324B6 (fr)
DE (1) DE60033280T2 (fr)
DK (1) DK1185525T3 (fr)
ES (1) ES2280198T3 (fr)
HK (1) HK1044943B (fr)
HR (1) HRP20010630B1 (fr)
HU (1) HUP0200080A3 (fr)
ID (1) ID30484A (fr)
IL (1) IL145051A0 (fr)
MA (1) MA26776A1 (fr)
NO (1) NO320809B1 (fr)
NZ (1) NZ513671A (fr)
PL (1) PL198815B1 (fr)
PT (1) PT1185525E (fr)
RS (1) RS50109B (fr)
RU (1) RU2201928C1 (fr)
TR (1) TR200102562T2 (fr)
WO (1) WO2000052007A1 (fr)
ZA (1) ZA200107157B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140724A (en) 2000-07-21 2010-01-15 Actelion Pharmaceuticals Ltd Novel arylethene-sulfonamides
US20020184047A1 (en) * 2001-04-03 2002-12-05 Plotnick Michael A. Universal ad queue
EP1454625A1 (fr) * 2003-03-06 2004-09-08 Speedel Development AG Pyridylsulfonamidyl-pyrimidines pour le traitement des néphropaties diabétiques
EP1595880A1 (fr) * 2004-05-13 2005-11-16 Speedel Pharma AG Formes crystallines d'un pyridinylsulphonamide et leur utilisation comme antagonistes du récepteur de l'endothéline
BRPI0615794A2 (pt) * 2005-09-12 2011-05-24 Speedel Pharma Ag piridilsulfonamidil-pirimidinas para a prevenção de falha de enxerto de vaso sangüìneo
BRPI0709950A2 (pt) * 2006-04-13 2011-08-02 Actelion Pharmaceuticals Ltd uso de bosentan na preparação de um medicamento para o tratamento de fibrose pulmonar idiopática em estágio precoce e uso de antagonista do receptor endotelin
EP1938812A1 (fr) * 2006-12-22 2008-07-02 Speedel Pharma AG Composition pharmaceutique utilisant aliskiren et avosentan
WO2010011868A2 (fr) * 2008-07-23 2010-01-28 Auspex Pharmaceuticals Modulateurs de pyridine sulfonamide du récepteur a de l'endothéline
CA2975260C (fr) 2015-01-29 2024-05-21 Signal Pharmaceuticals Llc Isotopologues de 2-(tert-butylamino)-4-((1r,3r,4r) -3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide
KR101936054B1 (ko) 2017-06-23 2019-01-11 한국과학기술연구원 항염증 활성을 가지는 6-페녹시피리미딘 유도체, 이의 제조방법 및 이를 활성성분으로 하는 약학 조성물
WO2023111299A1 (fr) 2021-12-17 2023-06-22 Idorsia Pharmaceuticals Ltd Sel disodique de clazosentan, sa préparation et compositions pharmaceutiques le comprenant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837708A (en) 1994-11-25 1998-11-17 Hoffmann-La Roche Inc. Sulphonamides
CA2162630C (fr) 1994-11-25 2007-05-01 Volker Breu Sulfonamides
CN1064965C (zh) * 1994-11-25 2001-04-25 弗·哈夫曼-拉罗切有限公司 新的磺酰胺类化合物及其作为药物的用途
TW313568B (fr) * 1994-12-20 1997-08-21 Hoffmann La Roche
EP0897914B1 (fr) 1997-08-19 2004-05-26 F. Hoffmann-La Roche Ag Procédé pour la préparation de pyridines 2,5-disubstitués
TWI284642B (en) * 1999-01-18 2007-08-01 Hoffmann La Roche Novel heterocyclic sulfonamides

Also Published As

Publication number Publication date
RU2201928C1 (ru) 2003-04-10
NO320809B1 (no) 2006-01-30
EP1185525B1 (fr) 2007-02-07
KR20010102480A (ko) 2001-11-15
ATE353325T1 (de) 2007-02-15
MA26776A1 (fr) 2004-12-20
JP3488203B2 (ja) 2004-01-19
TR200102562T2 (tr) 2002-02-21
US6417360B1 (en) 2002-07-09
CY1108002T1 (el) 2013-09-04
CA2364906C (fr) 2006-01-10
KR100478798B1 (ko) 2005-03-24
PL198815B1 (pl) 2008-07-31
CZ20013108A3 (cs) 2002-02-13
HK1044943B (zh) 2013-03-22
US20020137933A1 (en) 2002-09-26
IL145051A0 (en) 2002-06-30
PL351794A1 (en) 2003-06-16
EP1185525A1 (fr) 2002-03-13
AU3161100A (en) 2000-09-21
NO20014224D0 (no) 2001-08-31
HUP0200080A3 (en) 2003-01-28
CA2364906A1 (fr) 2000-09-08
HRP20010630A2 (en) 2002-08-31
HRP20010630B1 (en) 2010-08-31
DK1185525T3 (da) 2007-06-04
HUP0200080A2 (en) 2002-06-29
AU756738B2 (en) 2003-01-23
ZA200107157B (en) 2002-11-29
AR044720A1 (es) 2005-10-05
PT1185525E (pt) 2007-05-31
YU62801A (sh) 2004-07-15
HK1044943A1 (fr) 2002-11-08
US6521631B2 (en) 2003-02-18
WO2000052007A1 (fr) 2000-09-08
BR0008717A (pt) 2001-12-26
RU2001126348A (ru) 2004-03-20
CZ300324B6 (cs) 2009-04-22
CN1342158B (zh) 2012-06-06
NZ513671A (en) 2003-04-29
NO20014224L (no) 2001-08-31
DE60033280T2 (de) 2007-11-22
RS50109B (sr) 2009-03-25
DE60033280D1 (de) 2007-03-22
ES2280198T3 (es) 2007-09-16
CN1342158A (zh) 2002-03-27
JP2002538156A (ja) 2002-11-12

Similar Documents

Publication Publication Date Title
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
ID26420A (id) Indolinon-indolinon tersubstitusi baru, pembuatannya dan penggunaannya sebagai komposisi-komposisi farmasi
CY2015041I1 (el) Παραγωγα 4- φαινυλπυριδινης και η χρηση αυτων ως ανταγωνιστες του υποδοχεα νκ-1
ID26099A (id) Turunan amida dan antagonis nosiseptin
EE200000778A (et) 4-bensüülpiperidiinalküülsulfoksiidi heterotsüklid ja nende kasutamine NMDA retseptori alaliikide suhtes selektiivsete antagonistidena
IS5581A (is) Ný efnasambönd og notkun þeirra sem jákvæðir beinar AMPA-viðtaka
AU5265599A (en) Amine compounds, their production and their use as somatostatin receptor antagonists or agonists
IL156939A0 (en) Urea derivatives as integrin alpha 4 antagonists
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
SI1170288T1 (en) Diphenylureum derivatives and their use as alpha2/5-HT2c antagonists
ID19417A (id) TURUNAN-TURUNAN ASAM KARBOKSILAT BARU, PEMBUATAN DAN PEMAKAIANNYA SEBAGAI ANTAGONIS RESEPTOR ET a/ET b TERCAMPUR
IS5295A (is) Azetidínýlprópýlpíperidín afleiður, milliefni og notkun sem mótlyf gegn kínínhröðun
ID22916A (id) Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin
AU2002352476A8 (en) Urea derivatives and their use as vanilloid receptor antagonists
ID27544A (id) Agonis dan antagonis muskarinat
ID26223A (id) Antagonis reseptor vitronektin
ID30484A (id) Turunan 4-heterosikliksulfonamidil 6 metoksi 5 (2 metoksi fenoksi) 2 piridil-pirimidin, pembuatannya dan penggunaan sebagai antagonis reseptor endotelin
ID28909A (id) Antagonis reseptor serotonin terenkapsulasi polimer yang dapat terurai hayati dan metode pembuatannya
ID16274A (id) Antagonis bradikinin heterosiklik pengganti-fluoroalkil dan fluoroalkoksi, proses pembuatan dan pemakaiannya
ID26665A (id) Antagonis vla-4
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina
ID26985A (id) Amina-amina polisiklik tiazolidin-2-ilidena, proses pembuatannya, dan penggunaannya a sebagai bahas farmasi
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID28811A (id) Antagonis reseptor vitronektin